Speed Used to Treat Menopause–The New Introduction of Amphetamines Instead of Estrogen Replacement
Sounds like an ad for a drug company or a woman’s menopausal dream? Amphetamine prescriptions instead of estrogen scripts for signs of confusion associated with menopause?
One researcher says that she measured women’s self-monitoring responses after being prescribe amphetamines to “help” with menopause symptoms, and the women reported improvement:
Epperson, a clinician, tells The Daily Beast that she began her research after noticing that more women were coming to her practice with worries about the early onset of dementia. As it turned out, their problems with memory, concentration and ability to focus at work usually weren’t actual dementia, but side effects of low estrogen levels associated with menopause.
Most menopausal women are treated with hormones but they aren’t effective for all women and aren’t even an option for those with certain medical conditions. That’s where Epperson says stimulants might be able to step in.
“[Estrogen’s] decline during the menopausal years, we believe, can play a role in the simultaneous decline in executive function that many women experience during the menopause transition. More specifically, estrogen plays a role in dopamine levels and the brain’s normal dopaminergic tone. We theorize that this process can result in symptoms similar to those experienced by people with attention deficit hyperactivity disorder,” Epperson said in statement released before the presentation.
Epperson conducted the double-blind crossover study of 32 “successful” women (participants had an average of 16 years of education and an IQ of 113) between the ages of 48 and 60 with no history of ADHD, who reported diminished ability to focus and multi-task in their early post-menopausal years. Over four weeks, half of the women were given LDX and the other half a placebo, then measured on self reports of functioning in five areas: organization and motivation for work; concentration and attention; alertness, effort and processing speed; managing affective interference (letting emotions inhibit performance); and working memory and recall. The women who received LDX treatment, the preliminary evidence shows, had a significant reduction in the severity of all symptoms but one (the over-attention to emotion, which wasn’t a major complaint to begin with), but especially in the domain of organization and motivation for work. The women with the most severe symptoms experienced the most striking improvement; still others showed no improvement al all.
Another person claims that these are flashbacks to the use of amphetamine prescriptions for stay-at-home-moms used during the 1950’s who were overwhelmed or underhappy with their lives or gender roles.
“When I hear about this type of approach—taking common life changes where one might feel a little more distractible, or having trouble with memory when one gets older—and applying amphetamines, it makes me have a flash back,” Pieter Cohen, an assistant professor of medicine at Harvard Medical School, tells The Daily Beast.
As Cohen recounts and Nicolas Rasmussen details in his book On Speed: The Many Lives of Amphetamine, since their initial release in 1937, amphetamines have been used to improve the performance of American soldiers in WWII, stave off depression and weight gain in 1950’s housewives, and eventually to treat narcolepsy and Hyperkinetic Reaction of Childhood (or ADHD as we now know it).
So where does this hype for speed prescriptions come from for treating menopause? From the drug manufacturer of course:
The prescription of stimulants would also be inappropriate for women with hypertension (stimulants can increase blood pressure, heart rate, and body temperature) or a history of addiction, Epperson told The Daily Beast. She also noted that LDX maker, Shire—a company that has provided grant and/or research support, according to her disclosure—said the study wasn’t large enough to say the drug is a suitable treatment for all menopausal women, just these menopausal women in the study.
Oh look! The drug manufacturer found in its own study that it paid for that amphetamines really do help women with menopause! And with that little manufacturer-paid-for-study, women in menopause have also been labeled as having cognitive dysfunction. Anyone else having flashbacks to “mommy’s little helper” propaganda? Perhaps the advice now is to take one little dose of speed and call me when you get addicted?
Speed or amphetamines are addictive, highly addictive, and part of the reason they are so addictive is that they make the brain feel like everything is better as a function of their action.
Pharmaceutical companies pushed these drugs—promising to put the pep back in your step—but prescriptions fell after the addictive potential of the stimulants became clear, and they were added to the Drug Enforcement Administration’s list of “controlled substances” as a Schedule II, meaning they have a high potential for abuse and dependence.
“Once you sop taking it you feel like something’s missing,” Cohen says.“It might not be an addiction where you’re racing around trying to find your next hit, but it can cause dependence, and in some cases, addiction.”
As for the UPenn study, though it hasn’t been released yet, Cohen is dubious.
“It’s absurd to draw any conclusions from a few dozen women who self report being more productive after taking Speed. That’s what this drug does, it makes people feel better, so of course your self assessment of your capabilities would increase,” he says.
Addiction in menopause? Increased cancer risks? When will people realize that when it comes to menopause women might be better off left alone?